FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099690830> ?p ?o ?g. }

• W2099690830 endingPage "1165" @default.
• W2099690830 startingPage "1158" @default.
• W2099690830 abstract "Tenofovir is a new effective treatment option for patients with chronic hepatitis B, but could be potentially hampered by mutations in the hepatitis B virus (HBV) polymerase conferring drug resistance. Drug resistance may occur preferentially if long-term administration is required, for example, in patients with hepatitis B e antigen (HBeAg)-negative HBV infection bearing precore (PC) and basal core promoter (BCP) mutations. The rtA194T polymerase mutation has been found in HBV/HIV coinfected patients during tenofovir treatment and may be associated with tenofovir resistance. We generated replication-competent HBV constructs harboring rtA194T alone or in addition to lamivudine (LAM) resistance (rt180M + rtM204V), PC mutations, and BCP mutations and assessed their replicative capacity after transient transfection in human hepatoma cells. The rtA194T polymerase mutation alone or in conjunction with LAM resistance reduced the replication efficiency as compared with wild-type (WT) HBV. In contrast, combination of rtA194T (± LAM resistance) with HBeAg-negative PC or BCP mutants increased the replication capacity of the drug-resistant polymerase mutants, thereby restoring the viral replication to similar levels as WT clones. Clones harboring rtA194T showed partial resistance to tenofovir in vitro and also to LAM but remained susceptible to telbivudine and entecavir. Conclusion: The rtA194T polymerase mutation is associated with partial tenofovir drug resistance and negatively impacts replication competence of HBV constructs. Viral replication, however, can be restored to WT levels, if these polymerase mutations occur together with precore or basic core promoter substitutions as found in HBeAg-negative hepatitis B. Patients with HBeAg-negative chronic HBV infection may therefore be at particular risk when developing drug resistance to tenofovir. Telbivudine or entecavir should be considered as effective alternative treatment options for these patients. (HEPATOLOGY 2009.)" @default.
• W2099690830 created "2016-06-24" @default.
• W2099690830 creator A5000874547 @default.
• W2099690830 creator A5006242340 @default.
• W2099690830 creator A5010542715 @default.
• W2099690830 creator A5030491198 @default.
• W2099690830 creator A5074064604 @default.
• W2099690830 creator A5083825910 @default.
• W2099690830 date "2008-12-23" @default.
• W2099690830 modified "2023-10-15" @default.
• W2099690830 title "The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains" @default.
• W2099690830 cites W1579402809 @default.
• W2099690830 cites W1589359966 @default.
• W2099690830 cites W1597156005 @default.
• W2099690830 cites W1631507265 @default.
• W2099690830 cites W1653182164 @default.
• W2099690830 cites W1966895044 @default.
• W2099690830 cites W1973933851 @default.
• W2099690830 cites W2002548940 @default.
• W2099690830 cites W2004139194 @default.
• W2099690830 cites W2011946598 @default.
• W2099690830 cites W2014365367 @default.
• W2099690830 cites W2014500655 @default.
• W2099690830 cites W2016887997 @default.
• W2099690830 cites W2028175659 @default.
• W2099690830 cites W2040337342 @default.
• W2099690830 cites W2041308682 @default.
• W2099690830 cites W2044553804 @default.
• W2099690830 cites W2057435664 @default.
• W2099690830 cites W2058388169 @default.
• W2099690830 cites W2066652047 @default.
• W2099690830 cites W2071337588 @default.
• W2099690830 cites W2089440001 @default.
• W2099690830 cites W2095444472 @default.
• W2099690830 cites W2102271923 @default.
• W2099690830 cites W2103112398 @default.
• W2099690830 cites W2109610217 @default.
• W2099690830 cites W2109619534 @default.
• W2099690830 cites W2111503313 @default.
• W2099690830 cites W2119612879 @default.
• W2099690830 cites W2133291642 @default.
• W2099690830 cites W2134595040 @default.
• W2099690830 cites W2136761089 @default.
• W2099690830 cites W2139858623 @default.
• W2099690830 cites W2142833456 @default.
• W2099690830 cites W2143075479 @default.
• W2099690830 cites W2143375642 @default.
• W2099690830 cites W2153078062 @default.
• W2099690830 cites W2167185739 @default.
• W2099690830 cites W2431972701 @default.
• W2099690830 cites W2439379994 @default.
• W2099690830 doi "https://doi.org/10.1002/hep.22790" @default.
• W2099690830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19263474" @default.
• W2099690830 hasPublicationYear "2008" @default.
• W2099690830 type Work @default.
• W2099690830 sameAs 2099690830 @default.
• W2099690830 citedByCount "122" @default.
• W2099690830 countsByYear W20996908302012 @default.
• W2099690830 countsByYear W20996908302013 @default.
• W2099690830 countsByYear W20996908302014 @default.
• W2099690830 countsByYear W20996908302015 @default.
• W2099690830 countsByYear W20996908302016 @default.
• W2099690830 countsByYear W20996908302017 @default.
• W2099690830 countsByYear W20996908302018 @default.
• W2099690830 countsByYear W20996908302019 @default.
• W2099690830 countsByYear W20996908302020 @default.
• W2099690830 countsByYear W20996908302021 @default.
• W2099690830 countsByYear W20996908302022 @default.
• W2099690830 crossrefType "journal-article" @default.
• W2099690830 hasAuthorship W2099690830A5000874547 @default.
• W2099690830 hasAuthorship W2099690830A5006242340 @default.
• W2099690830 hasAuthorship W2099690830A5010542715 @default.
• W2099690830 hasAuthorship W2099690830A5030491198 @default.
• W2099690830 hasAuthorship W2099690830A5074064604 @default.
• W2099690830 hasAuthorship W2099690830A5083825910 @default.
• W2099690830 hasConcept C104317684 @default.
• W2099690830 hasConcept C140704245 @default.
• W2099690830 hasConcept C159047783 @default.
• W2099690830 hasConcept C194575299 @default.
• W2099690830 hasConcept C2522874641 @default.
• W2099690830 hasConcept C2775940106 @default.
• W2099690830 hasConcept C2776175608 @default.
• W2099690830 hasConcept C2777382497 @default.
• W2099690830 hasConcept C2777410769 @default.
• W2099690830 hasConcept C2777869810 @default.
• W2099690830 hasConcept C2780593183 @default.
• W2099690830 hasConcept C2780617729 @default.
• W2099690830 hasConcept C2781144229 @default.
• W2099690830 hasConcept C54355233 @default.
• W2099690830 hasConcept C82381507 @default.
• W2099690830 hasConcept C86803240 @default.
• W2099690830 hasConceptScore W2099690830C104317684 @default.
• W2099690830 hasConceptScore W2099690830C140704245 @default.
• W2099690830 hasConceptScore W2099690830C159047783 @default.
• W2099690830 hasConceptScore W2099690830C194575299 @default.
• W2099690830 hasConceptScore W2099690830C2522874641 @default.
• W2099690830 hasConceptScore W2099690830C2775940106 @default.
• W2099690830 hasConceptScore W2099690830C2776175608 @default.

• next